Literature DB >> 24472274

Giant cell arteritis with visual loss following zoledronic acid infusion.

Samy Metyas1, Makary Ibrahim, John Solyman, Karen C Yeter, Daniel G Arkfeld.   

Abstract

Zoledronic acid is used in the treatment of osteoporosis. Giant cell artertitis may lead to vision loss. We report a case in which vision loss occurred after zoledronic acid infusion.
© 2013 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  clinical aspects; drug treatment; giant cell arteritis; osteoporosis; zoledronic acid

Mesh：

Substances：

Year:  2013        PMID： 24472274     DOI： 10.1111/1756-185X.12263

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN： 1756-1841            Impact factor:   2.454


  1 in total

1.  Continuous effect with long-term safety in zoledronic acid therapy for polyostotic fibrous dysplasia with severe bone destruction.

Authors:  Di Wu; Jie Ma; Suqing Bao; Haixia Guan
Journal:  Rheumatol Int       Date:  2014-09-18       Impact factor: 2.631
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.